Second, the sample size of the study is still relatively small; therefore, a larger and multi-center study discovering the relationship between α-synuclein in peripheral blood and disease activity is necessary to validate the practicality of using plasma and serum α-synuclein as a reliable biomarker for PD. Here, SNCA is linked to Parkinson disease.